Ono Pharmaceutical Co Ltd
TSE:4528
Ono Pharmaceutical Co Ltd
Operating Income
Ono Pharmaceutical Co Ltd
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Ono Pharmaceutical Co Ltd
TSE:4528
|
Operating Income
¥164B
|
CAGR 3-Years
21%
|
CAGR 5-Years
22%
|
CAGR 10-Years
20%
|
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
Operating Income
¥464.9B
|
CAGR 3-Years
7%
|
CAGR 5-Years
18%
|
CAGR 10-Years
17%
|
|
Daiichi Sankyo Co Ltd
TSE:4568
|
Operating Income
¥188B
|
CAGR 3-Years
37%
|
CAGR 5-Years
19%
|
CAGR 10-Years
5%
|
|
Otsuka Holdings Co Ltd
TSE:4578
|
Operating Income
¥294.7B
|
CAGR 3-Years
13%
|
CAGR 5-Years
32%
|
CAGR 10-Years
3%
|
|
Chugai Pharmaceutical Co Ltd
TSE:4519
|
Operating Income
¥444.2B
|
CAGR 3-Years
14%
|
CAGR 5-Years
29%
|
CAGR 10-Years
19%
|
|
Astellas Pharma Inc
TSE:4503
|
Operating Income
¥142B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
3%
|
See Also
What is Ono Pharmaceutical Co Ltd's Operating Income?
Operating Income
164B
JPY
Based on the financial report for Dec 31, 2023, Ono Pharmaceutical Co Ltd's Operating Income amounts to 164B JPY.
What is Ono Pharmaceutical Co Ltd's Operating Income growth rate?
Operating Income CAGR 10Y
20%
Over the last year, the Operating Income growth was 14%. The average annual Operating Income growth rates for Ono Pharmaceutical Co Ltd have been 21% over the past three years , 22% over the past five years , and 20% over the past ten years .